Gomez, P, Sanchez, J


  • Deciding who and how to screen for T1D has broad clinical and research implications.
  • Several screening programs exist with goals of early detection of T1D and possible entry into prevention and/or new-onset trials.
  • In pediatric patients at increased risk of T1D, OGTT is the gold standard for disease staging and assisting in predicting risk of progression, especially when incorporated in a T1D risk score.
  • Unless overt symptoms of DM are present at diagnosis, testing should be repeated to
    confirm the diagnosis.

Click here to view the article!

If you are a member of the T1DX-QI, you can view the full pdf in the portal.